This inventor holds 18 USPTO granted patents and 2 published patent applications and 5 EPO patents. Top assignees: Isofol Medical Ab, University of Southern California, Other. Active years: 1983-2026.
Location History:
- Vastra Frolunda, SE (1983 - 1986)
- 79 Vastra Frolunda, SE (1987 - 1990)
- Gothenburg, SE (1994)
- Goteborg, SE (1986 - 1996)
- Västra Frölunda, SE (2015 - 2017)
- Västra Froelunda, SE (2019 - 2022)
Company Filing History:
9 out of 10 
2 out of 1,693 
7 out of 834,453 Years Active: 1983-2026
Title: The Innovations of Bengt Gustavsson
Introduction
Bengt Gustavsson is a notable inventor based in Vastra Frolunda, Sweden. He has made significant contributions to the field of medical science, particularly in cancer treatment. With a total of 17 patents to his name, his work has had a profound impact on therapeutic methods.
Latest Patents
Gustavsson's latest patents include innovative methods for increasing blood plasma 2'-deoxyuridine (dUrd) and thymidylate synthase inhibition. The present invention provides methods for increasing plasma dUrd levels through the administration of 6R-MTHF. These methods enhance dUrd levels compared to equimolar concentrations of LV. Additionally, he has developed methods for increasing TS inhibition, also involving the administration of 6R-MTHF. Another significant patent relates to the use of [6R]-5,10-methylenetetrahydrofolate as an efficient folate alternative in 5-fluorouracil based chemotherapy, particularly for treating solid tumors such as colorectal cancer.
Career Highlights
Throughout his career, Bengt Gustavsson has worked with various companies, including Isofol Medical AB. His innovative approaches have positioned him as a key figure in the development of new cancer therapies.
Collaborations
Gustavsson has collaborated with notable individuals in his field, including Göran U Carlsson and Anders Vedin. These partnerships have furthered his research and contributed to his success as an inventor.
Conclusion
Bengt Gustavsson's contributions to medical science through his patents and collaborations highlight his dedication to improving cancer treatment. His innovative methods continue to pave the way for advancements in the field.